NCT06514261 2026-03-19Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AMLNational Cancer Institute (NCI)Phase 1 Recruiting45 enrolled